Web-based tailored Information and support for patients with a Neuroendocrine tumor

Completed

• Conditions: psychosociale problemen; neuroendocrine tumor/distress; quality of life; 10014713

• Registration Number: NL-OMON41814
• Lead Sponsor: niversitair Medisch Centrum Groningen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 90

Inclusion Criteria

• Adult NET patients (aged >= 18 years of age) with any tumor site and disease stage.
• Ability to comprehend Dutch (both reading and writing).
• Informed consent provided.

Exclusion Criteria

• Estimated life expectancy less than 3 months.
• Patients who have a history of another primary malignancy, except for radical and adequately treated malignancies from which the patient has been disease free for >= 3 years
• Patients who participated in the WIN-pilot study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint is the difference in distress measured by the distress<br /><br>thermometer and the mean improvement of the global score of the EORTC QLQ-INFO<br /><br>25 at end of study between the control group and the intervention group. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints will be change in quality of life as determined by the<br /><br>cancer-specific EORTC QLQ-C30, and the EORTC QLQ-GINET21, empowerment<br /><br>(subscales of the Construct Empowering Outcomes questionnaire) at end of study,<br /><br>and to have information about patients* opinion and use of the web-based<br /><br>tailored information and support system (using a constructed questionnaire). </p><br>